Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein subunit gamma 2 (GNG2) is a member of the gamma subunit family of heterotrimeric G proteins, which are essential regulators of cellular responses to a broad array of extracellular signals mediated through G protein-coupled receptors (GPCRs). The G protein complex consists of alpha, beta, and gamma subunits; GNG2 forms a stable dimer with the beta subunit and plays a key role in transducing signals from activated receptors by enabling dissociation and subsequent activation of downstream effectors such as PLCβ, ion channels, and other signaling pathways. GNG2 is membrane-associated due to lipid modifications and exhibits unique translocation kinetics that regulate how signaling is distributed inside the cell. Disease relevance is highlighted by its tumor suppressor function in breast cancer, involvement in aortic aneurysm, and effects on cell cycle, apoptosis, and migration. Gains or losses in GNG2 function have distinctive phenotypic consequences, and its signaling specificity offers both challenges and opportunities for therapeutic modulation.
Modulation of GPCR signaling cascades (upstream receptor agonists and antagonists indirectly influence GNG2 function); Alteration of βγ subunit-mediated effector activation (e.g., influencing PLCβ, ion channels, and downstream signaling); Some chemotherapeutics may act via pathway suppression or enhancement involving GNG2 in cancer models.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein subunit gamma 2 (GNG2).